{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06381102",
            "orgStudyIdInfo": {
                "id": "20240134"
            },
            "organization": {
                "fullName": "University of Miami",
                "class": "OTHER"
            },
            "briefTitle": "Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1",
            "officialTitle": "How Does the Length of Pulse Trains and Pulse Intervals Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation?",
            "therapeuticArea": [
                "Other"
            ],
            "study": "transcutaneous-vagus-nerve-stimulation-tavns-dosage-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-19",
            "studyFirstSubmitQcDate": "2024-04-19",
            "studyFirstPostDateStruct": {
                "date": "2024-04-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Marlon Wong",
                "investigatorTitle": "Associate Professor of Clinical",
                "investigatorAffiliation": "University of Miami"
            },
            "leadSponsor": {
                "name": "University of Miami",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to investigate the effects of different forms of a gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS). The research team is interested in how the different forms affect comfort and tolerability, as well as how well it works."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "taVNS 30/30 followed by taVNS 10/10 group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in the group taVNS 30/30 followed by taVNS 10/10 will be in this group for up to 6 hours.",
                    "interventionNames": [
                        "Device: transcutaneous auricular vagus nerve stimulation 30/30",
                        "Device: transcutaneous auricular vagus nerve stimulation 10/10"
                    ]
                },
                {
                    "label": "taVNS 10/10 followed by taVNS 30/30 group",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants in the group taVNS 10/10 followed by taVNS 30/30 will be in this group for up to 6 hours.",
                    "interventionNames": [
                        "Device: transcutaneous auricular vagus nerve stimulation 30/30",
                        "Device: transcutaneous auricular vagus nerve stimulation 10/10"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "transcutaneous auricular vagus nerve stimulation 30/30",
                    "description": "Transauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN). Participants in this group will first receive taVNS with a 30 second on and 30 second off, for 1 hour, in-person.",
                    "armGroupLabels": [
                        "taVNS 10/10 followed by taVNS 30/30 group",
                        "taVNS 30/30 followed by taVNS 10/10 group"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "transcutaneous auricular vagus nerve stimulation 10/10",
                    "description": "Transauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN). Participants in this group will first receive taVNS with a 10 second on and 10 second off, for 1 hour, in-person.",
                    "armGroupLabels": [
                        "taVNS 10/10 followed by taVNS 30/30 group",
                        "taVNS 30/30 followed by taVNS 10/10 group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Tolerability measured by tolerability questionnaire",
                    "description": "Tolerability will be assessed with a questionnaire with scores ranging from 0 (no discomfort)-10 (worst pain imaginable) for comfort.",
                    "timeFrame": "Up to 3 hours."
                },
                {
                    "measure": "Tolerability measured by self-report",
                    "description": "Tolerability will be assessed using semi-structured interviews. Investigators will ask about the sensations experienced and preferences. Participants will self-report their responses.",
                    "timeFrame": "Up to 3 hours."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in heart rate variability (HRV)",
                    "description": "HRV will be measured with an H10 chest strap device. Values after stimulation will be subtracted from baseline values; thus, a positive number will indicate an increase in HRV post taVNS.",
                    "timeFrame": "Baseline and up to 3 hours."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. between the ages of 18-80 years\n2. English speaking (must be able to consent and complete the interviews in English)\n\nExclusion Criteria:\n\n1. chronic pain (average intensity \\&gt;2/10 on 0-10 scale, for longer than 3 months)\n2. acute pain of intensity greater than 3/10\n3. chronic inflammatory conditions that are poorly controlled (e.g., diabetes, autoimmune disease)\n4. any unstable medical condition or medical contraindication to moderate physical exertion (e.g., unstable angina or cardiac arrythmia)\n5. pregnancy\n6. currently taking Buprenorphine or recently stopped taking (within 1 month)\n7. presence of cognitive impairment or language barrier that impairs full autonomy in the consent process or in the ability to participate in detailed interviews\n8. implants in the head or neck, cochlear implants, or pacemaker\n9. head or neck metastasis or recent ear trauma\n10. history of epilepsy\n11. history of autonomic nervous system dysfunction (e.g., postural orthostatic tachycardia syndrome).",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marlon Wong, DPT, PhD",
                    "role": "CONTACT",
                    "phone": "305-243-8117",
                    "email": "mwong2@miami.edu"
                },
                {
                    "name": "Gabriel Gonzalez, DPT",
                    "role": "CONTACT",
                    "phone": "3052438117",
                    "email": "gxg651@miami.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marlon Wong, DPT, PhD",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Miami",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gabriel Gonzalez, DPT",
                            "role": "CONTACT",
                            "phone": "305-243-8117",
                            "email": "gxg651@miami.edu"
                        },
                        {
                            "name": "Marlon Wong, PT, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Gabriel Gonzalez, DPT",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Jessica Bolanos, DPT",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}